Scotland: Hope for patients with pulmonary fibrosis
The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland for the treatment of patients...
Tag: Nintedanib
Victory for thousands of terminally ill patients
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than most cancers. · Action for...
